Presence of Fas and Bcl-2 proteins in BEL-7404 human hepatoma cells

World Journal of Gastroenterology

Volumn 4, Issue 1-6, 1998, Pages 540-543

  Wang, Xing Wang ^a,b,c,d,e   Xie, Hong ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b Zhejiang Medical University ^*

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

^e SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; Bcl 2 proteins; BEL 7404; Fas gene; Gene expression; Liver neoplasms

Indexed keywords

EID: 0001211925     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v4.i6.540     Document Type: Article

References (15)

1. Wang XW, Xie H. Significance of alpha-fetoprotein in the development of novel therapeutic agents. Drugs Fut, 1998;23(7):in press
2. Wang XW, Xu B. Stimulation of tumor-cell growth by alpha-fetoprotein. Int J Cancer, 1998;75(4):596-599
3. Dudich E, Semenkova L, Gorbatova E,! Dudich I, Khromykh L, Tatulov E et al. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumor Biol, 1998;19(1):30-40
4. Kerr JFR, Winterford CM, Harmon BV.! Apoptosis: its significance in cancer and cancer therapy. Cancer, 1994;73(8):2013-2026
5. Marx J. Cell death studies yield cancer clues. Science, 1993;259(5):760-761
6. Laderoute MP, Pilarski LM. The inhibition of apoptosis by AFP and the role of AFP receptors in anti-cellular senescence. Anticancer Kes, 1994;14(6):2429-2438
7. Semenkova LN, Dudich EI, Dudich IV. Induction of apoptosis in human hepatoma cells by alpha-fetoprotein. Tumor Biol, 1997;18(5):261-273
8. Goyns MH. Apoptosis-the key to future anticancer therapy? Drugs Fut, 1995;20 (6):601-608
9. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes; regulators of cell death. Blood, 1992;80(5):879-886
10. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol, 1994; 124(1):1-6
11. Mizejewski GJ. Alpha-fetoprotein as a biologic response modifier: relevance to domain and subdomain structure. Proc Soc Exp Biol Med, 1997;215(4):333-362
12. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled anti-body (PAP) procedures. J Histochem Cytochem, 1981;29(4):577-580
13. Bois-Joyeux B, Thomassin H, Richard F, Ikonomova R, Denissenko M, Danan JL. Several transcription factors participate in the functioning of the alpha-fetoprotein gene promoter. Bull Cancer, 1995;82(7):541-550
14. Toumier-Thumeyssen I, Feldmann G, Bemuau D. Nuclear oncogenes and alpha-fetoprotein gene expression in hepatoma cell lines. Tumor Biol, 1993; 14(4):201 -212
15. Zou HQ, Tang ZY, Ye SL. Mutation of p53 gene and expression of alpha-fetoprotein during hepatocarcinogenesis. Chin J Med, 1994;74(8):474-475